Marketing Analysis and Availability of Drugs with ATC Code N07BB: Current Trends
DOI:
https://doi.org/10.53933/sspmpm.v4i4.167Keywords:
marketing analysis, availability, alcohol addiction, pharmacotherapy, Disulfiram, Naltrexone, combined drugs, dispensing regimenAbstract
Marketing analysis was conducted and the availability of drugs for the treatment of alcohol addiction under the ATX code N07BB was assessed. The study covers three main clinical and pharmacological groups: Disulfiram (N07BB01), Naltrexone (N07BB04) and other drugs (N07BB10). The features of the release forms (tablets, granules, powders), availability and release regimens were analyzed. Disulfiram and Naltrexone drugs are available by prescription, while combined drugs are available without a prescription. The data obtained indicate a high potential for the use of these drugs for individualized and affordable therapy of alcohol addiction.
A thorough marketing assessment was undertaken to evaluate the availability of medications under ATX code N07BB, focusing on their role in alcohol addiction treatment. The analysis covered three principal clinical and pharmacological categories: Disulfiram (N07BB01), Naltrexone (N07BB04), and an additional subgroup of products (N07BB10). Researchers examined various dosage forms – including tablets, granules, and powders – alongside their accessibility and distribution requirements. Disulfiram and Naltrexone both require a physician’s authorization, while certain combination therapies can be purchased without a prescription. Based on these data, there is clear evidence of a robust potential for these therapies to be used in personalized and cost-effective interventions for alcohol dependence. Moreover, their availability in multiple formats caters to patients’ individual preferences and clinical needs, potentially enhancing adherence and treatment success. By offering a wide variety of administration possibilities, these medications are poised to improve outcomes in different healthcare settings. Research into dosing schedules and side effects can guide clinicians in refining therapeutic approaches. Healthcare professionals may consider these agents as part of a strategy, incorporating psychosocial support and other interventions that address the nature of alcohol dependence.
References
Improving prevention and treatment for drug use disorders. WHO. URL: https://www.who.int/activities/improving-prevention-and-treatment-for-drug-use-disorders.
Health and social responses to drug problems: a European guide. EMCDDA. October 2021. URL: https://www.emcdda.europa.eu/publications/health-and-social-responses-a-european-guide_en.
International standards for the treatment of disorders related to the use of narcotic substances. Revised edition based on field research results. World Health Organization and United Nations Office on Drugs and Crime. Switzerland. UNODC. 2020. URL: https://www.unodc.org/documents/drug-prevention-and-treatment/UNODC-WHO_International_Standards_Treatment_Drug_Use_Disorders_2020_UKR_inoff.pdf
Medicine in the UK: from each - whenever possible, for everyone - on demand. https://www.vz.kiev.ua/medytsyna-velykoyi-brytaniyi-vid-kozhnogo-po-mozhlyvosti-kozhnomu-po-potrebi/
French Health Care System. URL: http://www.french-property.com/guides/france/public-services/health/system-overview
Osyntseva A. Polydrug addiction: multidisciplinary forensic and pharmaceutical, organizational and legal, and technological study of factors of formation and development. SSP Modern Pharmacy and Medicine. 2022. Vol.2. No.4. P.1-14. DOI: https://doi.org/10.53933/sspmpm.v2i4.72
2nd WHO Forum on alcohol, drugs and addictive behaviours. WHO. 27.06.2019. URL: https://www.who.int/news-room/events/detail/2019/06/27/default-calendar/who-forum-on-alcohol-drugs-and-addictive-behaviours.
Non-medical use of medicines: health and social responses. EMCDDA. 20.10.2021. URL: https://www.emcdda.europa.eu/publications/mini-guides/non-medical-use-of-medicines-health-and-social-responses_en.
Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.1. P.1-13. URL: https://doi.org/10.53933/sspmpm.v2i1.37. DOI: https://doi.org/10.53933/sspmpm.v2i1.37
ICD-11. International Classification of Diseases 11th Revision. The global standard for diagnostic health information. WHO. 2019. URL: https://icd.who.int/en
Shapovalova V., Zakharchenko I. Organizational and legal approaches to reforming of the law enforcement system of Ukraine: illegal circulation of psychoactive substances and addictive dependence. SSP Modern Law and Practice. 2021. Vol. 1. Nо.1. P.1–22. DOI: https://doi.org/10.53933/sspmlp.v1i1.20. DOI: https://doi.org/10.53933/sspmlp.v1i1.20
Shapovalov (Jr.) V., Gudzenko A., Shapovalova V. et al. Forensic and pharmaceutical analysis of addictive morbidity because of the use of narcotic psychoactive substances in Ukraine (retrospective aspect). International Journal of Pharmaceutical Sciences and Research. 2018. Vol. 3. Is.3. July 2018. P.22-25. URL: http://www.pharmacyjournal.net/archives/2018/vol3/issue3
Shapovalov V. (Jr.), Gudzenko A., Shapovalova V. еt аl. Forensic and pharmaceutical study of the presence of a causal link between the degree of alcohol abuse and qualification level of the respondents. Pharmacia. 2017. Vol.66. Nо.3. Р. 31–39. URL: http://bsphs.org/wp-content/uploads/2017/11/Shapovalov.pdf.
Sosin I.K., Chuev Yu.F., Artemchuk A.P. et al. Narcology: national textbook. Kharkiv, Ukraine: Kolegium. 2014. 948 p.
Gubskyi Y.I., Shapovalova V.O., Kutko I.I. et al. Medicines in psychopharmacology. K.: "Health", Kharkiv: "Torsing".1997. 288 p.
Shapovalova V.A., Sosyn I.K., Butenko G.M. et al. Pharmaceutical law in narcology. Kharkov: "Fact". 2004. 800 p.
Shapovalova V.A., Voloshyn P.V., Stefanov A.V. et al. Medicines for neurologists, psychiatrists and narcologists. Kh.: Fakt. 2003. 784 p.
Study to prevent deaths from opioid overdose shows promising results. WHO. 06.08.2021. URL: https://www.who.int/news/item/06-08-2021-study-to-prevent-deaths-from-opioid-overdose-shows-promising-results.
Improving prevention and treatment for drug use disorders. WHO. URL: https://www.who.int/activities/improving-prevention-and-treatment-for-drug-use-disorders.
Third WHO Forum on Alcohol, Drugs and Addictive Behaviours (FADAB). WHO. 22.06.2021. URL: https://www.who.int/news-room/events/detail/2021/06/22/default-calendar/third-who-forum-on-alcohol-drugs-and-addictive-behaviours-(fadab)
Osyntseva A. Organizational and legal study of the state of formation, development and distribution of polydrug addiction in the world and in Ukraine. SSP Modern Pharmacy and Medicine. Vol. 1 No. 2 (2021): Volume 1 No. 2 (2021). DOI: https://doi.org/10.53933/sspmpm.v1i2.26. DOI: https://doi.org/10.53933/sspmpm.v2i4.72
Making Mental Health & Well-Being for All a Global Priority. IASP. 5.10.2022. URL: https://www.iasp.info/2022/10/05/making-mental-health-well-being-for-all-a-global-priority/.
Shapovalov V.V., Gudzenko A.A., Zbrozhek S.I. et al. Forensic and pharmaceutical analysis of addictive morbidity because of the use of psychotropic psychoactive substances in Ukraine (retrospective aspect). Annals of Mechnikov Institute. 2018. N. 3. Р. 41–44. DOI: 10.5281/zenodo.1456544. URL: http://www.imiamn.org.ua/journal/3_2018/PDF/9.pdf.
Hayduchok I., Shapovalov V. Forensic pharmacy and medicine: risks for pharmacotherapy of addiction and countering of illegal circulation of psychoactive substances in the COVID-19 pandemic. 2021. SSP Modern Pharmacy and Medicine. Vol. 1. N. 2. P.1-28. https://doi.org/10.53933/sspmpm.v1i2.32. DOI: https://doi.org/10.53933/sspmpm.v1i2.32
Chuiev Y., Shapovalova V. Integrated ABC/VEN-analysis of drug prescriptions in pharmacotherapeutic schemes for relief of drunken forms of alcohol dependence. SSP Modern Pharmacy and Medicine. 2022. Vol.2. Nо.1. P.1-14. URL: https://doi.org/10.53933/sspmpm.v2i1.35 DOI: https://doi.org/10.53933/sspmpm.v2i1.35
Shapovalov V. (Jr.), Zbrozhek S., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol. 51. Nо. 1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.
Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P. 1–24. DOI: https://doi.org/10.53933/sspmpm.v2i4.69. DOI: https://doi.org/10.53933/sspmpm.v2i4.69
ATC/DDD Index 2024. WHO Collaborating Centre for Drug Statistics Methodology. https://atcddd.fhi.no/atc_ddd_index/
Osyntseva A. Cannabinoid addiction: pharmacotherapy, forensic and pharmaceutical practice, availability of drugs. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.1. P.1-11. DOI: https://doi.org/10.53933/sspmpm.v3i1.83 DOI: https://doi.org/10.53933/sspmpm.v3i1.83
Shapovalov V., Diachenko A. Interdisciplinary Forensic and Pharmaceutical Study of Illegal circulation of falsified alcoholic beverages to combat crime and prevent Public Health disorders. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.1. P.1-12. DOI: https://doi.org/10.53933/sspmpm.v3i1.86 DOI: https://doi.org/10.53933/sspmpm.v3i1.86
Lee N. America has spent over a trillion dollars fighting the war on drugs. 50 years later, drug use in the U.S. is climbing again. CNBC. 17.06.2021. URL: https://www.cnbc.com/2021/06/17/the-us-has-spent-over-a-trillion-dollars-fighting-war-on-drugs.html.
Shapovalov V. Intentional homicides committed while under the influence of alcohol during the pandemic: an interdisciplinary forensic and pharmaceutical, forensic and medical, forensic and narcological, criminalistics, and criminal and law study of a contemporary problem. SSP Modern Law and Practice. 2022. Vol.2. No.4. P.1-32. DOI: https://doi.org/10.53933/sspmlp.v2i4.74 DOI: https://doi.org/10.53933/sspmlp.v2i4.74
Barbosa C., Cowell A.J., Dowd W.N. Alcohol consumption in response to the COVID-19 pandemic in the United States. J. Addict. Med. 2021. Jul-Aug; No.15(4). P. 341-344. URL: https://pubmed.ncbi.nlm.nih.gov/33105169/ DOI: https://doi.org/10.1097/ADM.0000000000000767
On approval of the List of medicinal products permitted for use in Ukraine, which are dispensed without prescriptions from pharmacies and their structural divisions: Order of the Ministry of Health of Ukraine dated May 05, 2023 No. 848. Ministry of Health of Ukraine. URL: https://zakon.rada.gov.ua/laws/show/z0854-23#n17
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Valentyn Shapovalov, Anatolii Derkach
This work is licensed under a Creative Commons Attribution 4.0 International License.
